NOVARTIS GENE THERAPIES H-1B Visa Sponsorship & Salary Data

The median H-1B salary at NOVARTIS GENE THERAPIES is $98,218, based on 24 certified filings from FY 2021 to FY 2026. This is 18% lower than the national H-1B median salary of $120,000. Compensation at NOVARTIS GENE THERAPIES reflects their market positioning, with entry-level roles starting around $79,747 and senior positions reaching $141,378 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at NOVARTIS GENE THERAPIES range from $75,691 at the 10th percentile to $141,378 at the 90th percentile, showing a $65,687 spread across experience levels and roles. The 25th percentile is $79,747 and the 75th percentile is $112,320.

Yes, NOVARTIS GENE THERAPIES actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 24 H-1B labor condition applications from FY 2021 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 24 certified applications and a 0% denial rate, NOVARTIS GENE THERAPIES maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), NOVARTIS GENE THERAPIES filed 2 H-1B applications, with 2 certified and 0 denied. Over 5 years of data, NOVARTIS GENE THERAPIES has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

NOVARTIS GENE THERAPIES's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 24 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating NOVARTIS GENE THERAPIES as a potential H-1B sponsor.

This is an excellent approval rate, indicating NOVARTIS GENE THERAPIES has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

NOVARTIS GENE THERAPIES sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 24 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles NOVARTIS GENE THERAPIES most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at NOVARTIS GENE THERAPIES:

The most frequently sponsored role is Manufacturing Quality Assurance Specialist with 3 filings at a median salary of $78,874. This is followed by Senior Project Manager (2 filings) and Specialist, Quality Control.

NOVARTIS GENE THERAPIES's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where NOVARTIS GENE THERAPIES sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top NOVARTIS GENE THERAPIES H-1B locations:

The largest H-1B hub for NOVARTIS GENE THERAPIES is Durham, NC with 15 filings at a median salary of $98,218. The highest-paying location is Bannockburn, IL at $169,542 median. Salaries range from $79,747 to $169,542 across office locations.

NOVARTIS GENE THERAPIES's median H-1B salary has increased by +2% from FY 2021 ($96,054) to FY 2026 ($98,218). Tracking salary trends over time reveals how NOVARTIS GENE THERAPIES adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at NOVARTIS GENE THERAPIES.

Year-by-year breakdown:

• FY 2021: $96,054 (6 certified)
• FY 2022: $106,642 (6 certified)
• FY 2023: $99,466 (6 certified)
• FY 2025: $112,320 (4 certified)
• FY 2026: $98,218 (2 certified)

NOVARTIS GENE THERAPIES has maintained steady salary growth for H-1B positions over this period.

NOVARTIS GENE THERAPIES primarily files H-1B applications at Wage Level II, accounting for 43% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making NOVARTIS GENE THERAPIES's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 96% of positions at Level II or higher, NOVARTIS GENE THERAPIES typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

NOVARTIS GENE THERAPIES's median H-1B salary of $98,218 is 18% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating NOVARTIS GENE THERAPIES's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare NOVARTIS GENE THERAPIES's offerings with similar companies in your field for a more accurate assessment.

NOVARTIS GENE THERAPIES's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. NOVARTIS GENE THERAPIES's higher proportion of Level III-IV positions (52%) may benefit from wage-based lottery prioritization.

With 24 certified filings, NOVARTIS GENE THERAPIES invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.